Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700028409

Trial Profile

Clinical Trials Insight: 700028409

Phase of Trial: Phase II

Latest Information Update: 07 Apr 2008

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
  • Sponsors MAP Pharmaceuticals
  • Most Recent Events

    • 07 Apr 2008 Status changed from recruiting to completed according to a MAP Pharmaceuticals media release.
    • 07 Apr 2008 Positive results were reported in a MAP Pharmaceuticals media release.
    • 13 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top